Recent Analyst Stock Rating News
The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.Get Started for Free
Jeff Jones is an analyst at Oppenheimer. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 07/16/2024
| Buy Now | Get Alert | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 07/10/2024 | KYMR | Buy Now | Kymera Therapeutics | $45.01 | 15.53% | $52 → $52 | Maintains | Outperform | Get Alert |
| 07/10/2024 | CRBP | Buy Now | Corbus Pharmaceuticals | $59.26 | 35% | $80 → $80 | Reiterates | Outperform → Outperform | Get Alert |
| 06/18/2024 | CATX | Buy Now | Perspective Therapeutics | $12.45 | — | $2 → $19 | Reiterates | Outperform → Outperform | Get Alert |
| 06/07/2024 | MCRB | Buy Now | Seres Therapeutics | $1.16 | — | — | Downgrade | Outperform → Perform | Get Alert |
| 06/06/2024 | VTYX | Buy Now | Ventyx Biosciences | $2.89 | 246.02% | $12 → $10 | Maintains | Outperform | Get Alert |
| 06/03/2024 | CRBP | Buy Now | Corbus Pharmaceuticals | $59.26 | 35% | $60 → $80 | Maintains | Outperform | Get Alert |
| 05/10/2024 | ZURA | Buy Now | Zura Bio | $3.80 | 452.63% | $16 → $21 | Maintains | Outperform | Get Alert |
| 05/09/2024 | MCRB | Buy Now | Seres Therapeutics | $1.16 | 244.83% | $5 → $4 | Maintains | Outperform | Get Alert |
| 05/08/2024 | CRBP | Buy Now | Corbus Pharmaceuticals | $59.26 | 1.25% | $58 → $60 | Maintains | Outperform | Get Alert |
| 05/07/2024 | PLRX | Buy Now | Pliant Therapeutics | $13.44 | 257.14% | $47 → $48 | Reiterates | Outperform → Outperform | Get Alert |
| 05/07/2024 | CRVS | Buy Now | Corvus Pharma | $2.05 | 290.24% | $7 → $8 | Maintains | Outperform | Get Alert |
| 05/06/2024 | CMMB | Buy Now | Chemomab Therapeutics | $1.10 | 445.45% | → $6 | Upgrade | Perform → Outperform | Get Alert |
| 05/03/2024 | KYMR | Buy Now | Kymera Therapeutics | $45.01 | 15.53% | $53 → $52 | Maintains | Outperform | Get Alert |
| 04/22/2024 | KYMR | Buy Now | Kymera Therapeutics | $45.01 | 17.75% | → $53 | Initiates | → Outperform | Get Alert |
| 04/01/2024 | ZURA | Buy Now | Zura Bio | $3.80 | 321.05% | $17 → $16 | Reiterates | Outperform → Outperform | Get Alert |
| 04/01/2024 | CATX | Buy Now | Perspective Therapeutics | $12.45 | -87.95% | $12 → $15 | Reiterates | Outperform → Outperform | Get Alert |
| 04/01/2024 | ANTX | Buy Now | AN2 Therapeutics | $2.51 | — | — | Reiterates | Perform → Perform | Get Alert |
| 03/28/2024 | CLRB | Buy Now | Cellectar Biosciences | $2.61 | 359.77% | $11 → $12 | Reiterates | Outperform → Outperform | Get Alert |
| 03/20/2024 | CRVS | Buy Now | Corvus Pharma | $2.05 | 241.46% | $8 → $7 | Maintains | Outperform | Get Alert |
| 03/19/2024 | CATX | Buy Now | Perspective Therapeutics | $12.45 | -90.36% | $12 → $12 | Reiterates | Outperform → Outperform | Get Alert |
| 03/13/2024 | CRBP | Buy Now | Corbus Pharmaceuticals | $59.26 | -2.13% | $51 → $58 | Reiterates | Outperform → Outperform | Get Alert |
| 03/12/2024 | VTYX | Buy Now | Ventyx Biosciences | $2.89 | 315.22% | → $12 | Upgrade | Perform → Outperform | Get Alert |
| 03/08/2024 | CMMB | Buy Now | Chemomab Therapeutics | $1.10 | — | — | Maintains | Perform | Get Alert |
| 03/06/2024 | MCRB | Buy Now | Seres Therapeutics | $1.16 | 331.03% | $9 → $5 | Maintains | Outperform | Get Alert |
| 03/01/2024 | EVH | Buy Now | Evolent Health | $19.26 | 133.64% | → $45 | Initiates | → Outperform | Get Alert |
| 02/21/2024 | VTYX | Buy Now | Ventyx Biosciences | $2.89 | — | — | Reiterates | → Perform | Get Alert |
| 02/12/2024 | ANTX | Buy Now | AN2 Therapeutics | $2.51 | — | — | Downgrade | Outperform → Perform | Get Alert |
| 01/29/2024 | CRBP | Buy Now | Corbus Pharmaceuticals | $59.26 | -13.94% | $20 → $51 | Maintains | Outperform | Get Alert |
| 01/16/2024 | MCRB | Buy Now | Seres Therapeutics | $1.16 | 675.86% | $10 → $9 | Maintains | Outperform | Get Alert |
| 01/05/2024 | FUSN | Buy Now | Fusion Pharmaceuticals | — | — | $13 → $15 | Maintains | Outperform | Get Alert |
| 12/27/2023 | FUSN | Buy Now | Fusion Pharmaceuticals | — | — | $13 → $13 | Reiterates | Outperform → Outperform | Get Alert |
| 09/29/2023 | FUSN | Buy Now | Fusion Pharmaceuticals | — | — | → $13 | Initiates | → Outperform | Get Alert |
| 08/10/2023 | PLRX | Buy Now | Pliant Therapeutics | $13.44 | 286.9% | $51 → $52 | Maintains | Outperform | Get Alert |
| 08/09/2023 | CRBP | Buy Now | Corbus Pharmaceuticals | $59.26 | -62.88% | → $22 | Reiterates | Outperform → Outperform | Get Alert |
| 07/05/2023 | VTYX | Buy Now | Ventyx Biosciences | $2.89 | 2045.33% | → $62 | Reiterates | Outperform → Outperform | Get Alert |
| 06/07/2023 | CMMB | Buy Now | Chemomab Therapeutics | $1.10 | — | — | Downgrade | Outperform → Perform | Get Alert |
| 06/01/2023 | NOVN | Buy Now | Novan | — | — | — | Downgrade | Outperform → Perform | Get Alert |
| 05/25/2023 | CYCC | Buy Now | Cyclacel Pharmaceuticals | $1.71 | 367.81% | → $120 | Maintains | Outperform | Get Alert |
| 05/23/2023 | RAIN | Buy Now | Rain Oncology | — | — | — | Downgrade | Outperform → Perform | Get Alert |
| 05/19/2023 | CATX | Buy Now | Perspective Therapeutics | $12.45 | -90.36% | $10 → $12 | Maintains | Outperform | Get Alert |
| 05/16/2023 | PNT | Buy Now | POINT Biopharma Global | — | — | → $13 | Reiterates | Outperform → Outperform | Get Alert |
| 05/16/2023 | NOVN | Buy Now | Novan | — | — | $9 → $8 | Maintains | Outperform | Get Alert |
| 05/11/2023 | PMVP | Buy Now | PMV Pharma | $1.63 | 820.25% | → $15 | Reiterates | Outperform → Outperform | Get Alert |
| 05/10/2023 | PLRX | Buy Now | Pliant Therapeutics | $13.44 | 279.46% | $44 → $51 | Maintains | Outperform | Get Alert |
| 05/10/2023 | CRBP | Buy Now | Corbus Pharmaceuticals | $59.26 | -62.88% | → $22 | Upgrade | Perform → Outperform | Get Alert |
| 04/18/2023 | CMMB | Buy Now | Chemomab Therapeutics | $1.10 | 536.36% | $12 → $7 | Maintains | Outperform | Get Alert |
| 03/30/2023 | ANTX | Buy Now | AN2 Therapeutics | $2.51 | 856.18% | $20 → $24 | Maintains | Outperform | Get Alert |
| 03/24/2023 | MBRX | Buy Now | Moleculin Biotech | $4.45 | 12.36% | → $75 | Reiterates | → Outperform | Get Alert |
| 03/24/2023 | VTYX | Buy Now | Ventyx Biosciences | $2.89 | 2045.33% | $65 → $62 | Maintains | Outperform | Get Alert |
| 03/10/2023 | PLRX | Buy Now | Pliant Therapeutics | $13.44 | 227.38% | $43 → $44 | Maintains | Outperform | Get Alert |
| 03/07/2023 | CYCC | Buy Now | Cyclacel Pharmaceuticals | $1.71 | 367.81% | $150 → $120 | Maintains | Outperform | Get Alert |
| 03/02/2023 | PMVP | Buy Now | PMV Pharma | $1.63 | 820.25% | $28 → $15 | Maintains | Outperform | Get Alert |
| 03/01/2023 | RXDX | Buy Now | Prometheus Biosciences | — | — | $125 → $150 | Maintains | Outperform | Get Alert |
| 01/27/2023 | VTYX | Buy Now | Ventyx Biosciences | $2.89 | 1976.12% | $55 → $60 | Maintains | Outperform | Get Alert |
| 12/08/2022 | RXDX | Buy Now | Prometheus Biosciences | — | — | $61 → $125 | Maintains | Outperform | Get Alert |
| 11/17/2022 | EVAX | Buy Now | Evaxion Biotech | $3.05 | 260.66% | $160 → $110 | Maintains | Outperform | Get Alert |
| 10/11/2022 | PNT | Buy Now | POINT Biopharma Global | — | — | → $20 | Initiates | → Outperform | Get Alert |
| 10/04/2022 | RXDX | Buy Now | Prometheus Biosciences | — | — | $50 → $65 | Maintains | Outperform | Get Alert |
| 09/12/2022 | VTYX | Buy Now | Ventyx Biosciences | $2.89 | 2149.13% | $40 → $65 | Maintains | Outperform | Get Alert |
| 08/16/2022 | VTYX | Buy Now | Ventyx Biosciences | $2.89 | 1284.08% | $30 → $40 | Maintains | Outperform | Get Alert |
| 07/19/2022 | NOVN | Buy Now | Novan | — | — | → $12 | Initiates | → Outperform | Get Alert |
| 07/18/2022 | CLRB | Buy Now | Cellectar Biosciences | $2.61 | 110.73% | → $55 | Assumes | → Outperform | Get Alert |
| 07/18/2022 | CYCC | Buy Now | Cyclacel Pharmaceuticals | $1.71 | 894.09% | → $255 | Assumes | → Outperform | Get Alert |
| 07/18/2022 | EVAX | Buy Now | Evaxion Biotech | $3.05 | 424.59% | → $160 | Assumes | → Outperform | Get Alert |
| 07/18/2022 | MBRX | Buy Now | Moleculin Biotech | $4.45 | 214.61% | $30 → $210 | Assumes | → Outperform | Get Alert |
| 07/18/2022 | VBLT | Buy Now | Vascular Biogenics | — | — | → $192.5 | Assumes | → Outperform | Get Alert |
| 06/09/2022 | PMVP | Buy Now | PMV Pharma | $1.63 | 1924.54% | $30 → $33 | Maintains | Outperform | Get Alert |
| 04/01/2022 | RAIN | Buy Now | Rain Oncology | — | — | → $15 | Initiates | → Outperform | Get Alert |
| 03/10/2022 | CMMB | Buy Now | Chemomab Therapeutics | $1.10 | 1718.18% | $30 → $20 | Maintains | Outperform | Get Alert |
| 03/02/2022 | PMVP | Buy Now | PMV Pharma | $1.63 | — | — | Upgrade | Perform → Outperform | Get Alert |
| 02/01/2022 | VTYX | Buy Now | Ventyx Biosciences | $2.89 | 938.06% | → $30 | Initiates | → Outperform | Get Alert |
| 12/10/2021 | PLRX | Buy Now | Pliant Therapeutics | $13.44 | 197.62% | — | Initiates | → Outperform | Get Alert |
| 12/08/2021 | RXDX | Buy Now | Prometheus Biosciences | — | — | — | Upgrade | Perform → Outperform | Get Alert |
| 11/15/2021 | RXDX | Buy Now | Prometheus Biosciences | — | — | — | Downgrade | Outperform → Perform | Get Alert |
